Average Co-Inventor Count = 3.73
ph-index = 19
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (92 from 3,224 patents)
2. University of California (6 from 15,528 patents)
3. Genetech, Inc. (6 from 98 patents)
4. F. Hoffmann-La Roche Ag (1 from 168 patents)
5. St. Elizabeth's Medical Center of Boston, Inc. (1 from 11 patents)
6. Denis Gospodarowicz (0 patent)
7. Jean Plouet (0 patent)
8. Napoleone Ferrara (0 patent)
105 patents:
1. 12514905 - Methods and Compositions for Treatment of Angiogenic Disorders Using Anti-VEGF Agents
2. 11576948 - Long-acting VEGF inhibitors for intraocular neovascularization
3. 11524053 - Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents
4. 11433118 - Long-acting VEGF inhibitors for intraocular neovascularization
5. 11382955 - Long-acting VEGF inhibitors for intraocular neovascularization
6. 9273113 - Methods of inhibiting vascular endothelial growth factor activity
7. 9266948 - Anti-Bv8 antibodies and uses thereof
8. 8858936 - Compositions with hematopoietic and immune activity
9. 8771685 - Anti-BV8 antibodies and uses thereof
10. 8604185 - Inhibitors of angiopoietin-like 4 protein, combinations, and their use
11. 8557238 - EG-VEGF nucleic acids and polypeptides and methods of use
12. 8541376 - Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3
13. 8287873 - Vascular endothelial cell growth factor antagonists and uses thereof
14. 8273353 - Inhibitors of vascular endothelial growth factor activity
15. 8268591 - Compositions and methods for producing inhibitors of vascular endothelial growth factor activity